Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs propofol for hemodynamic stability during induction in GI tumor surgery
ChiCTR2500108853Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Sep 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypotension, None and gastrointestinal stromal tumor (GIST) comparing Ciprofol induction arm with Propofol induction arm (2 arms). Primary endpoint: Time-weighted cumulative area of mean arterial pressure reduction within 10 minutes after induction. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
ciprofolpropofol
03
Conditions
hypotensiongastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on ChiCTR2500108853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108853.